AXSM vs. INZY

In the year-to-date period, AXSM achieves a 28.00% return, which is significantly lower than INZY's 44.04% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Axsome Therapeutics, Inc. (AXSM) and Inozyme Pharma, Inc. (INZY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current AXSM Sharpe Ratio is 0.91, which is higher than the INZY Sharpe Ratio of -0.07. The chart below compares the historical Sharpe Ratios of AXSM and INZY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither AXSM nor INZY has paid dividends to shareholders.

The maximum AXSM drawdown since its inception was -86.65%, smaller than the maximum INZY drawdown of -97.28%. Use the drawdown chart below to compare losses from any high point for AXSM and INZY. For additional features, visit the drawdowns tool.

The current volatility for Axsome Therapeutics, Inc. (AXSM) is 9.58%, while Inozyme Pharma, Inc. (INZY) has a volatility of 110.45%. This indicates that AXSM experiences smaller price fluctuations and is considered to be less risky than INZY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Axsome Therapeutics, Inc. and Inozyme Pharma, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.